Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 8:14 PM UTC
| NCT Number | NCT06520345 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 520 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Telix Pharmaceuticals (Innovations) Pty Limited |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of July 20, 2026: Clinical trial NCT06520345 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 9 locations across the United States. The study is sponsored by Telix Pharmaceuticals (Innovations) Pty Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06520345 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06520345 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.